MedStart was acquired by Yazen for an undisclosed amount. The acquisition is part of Yazen's expansion strategy into Denmark, with the aim of leveraging MedStart's expertise in GLP-1 focused medical technology to further develop and commercialize innovative treatments for meta...
MedStart was acquired by Yazen for an undisclosed amount
Feb 21, 2025
—